Profile | GDS4284 / 211372_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 225.164 | 52 |
GSM687648 | Patient 402 control | 593.237 | 66 |
GSM687653 | Patient 403 control | 220.352 | 51 |
GSM687658 | Patient 404 control | 564.551 | 66 |
GSM687663 | Patient 411 control | 1203.04 | 77 |
GSM687668 | Patient 422 control | 193.963 | 48 |
GSM687673 | Patient 424 control | 399.022 | 59 |
GSM687678 | Patient 425 control | 697.949 | 68 |
GSM687683 | Patient 427 control | 335.703 | 56 |
GSM687688 | Patient 428 control | 142.018 | 41 |
GSM687695 | Patient 441 control | 7536.38 | 96 |
GSM687699 | Patient 443 control | 1554.1 | 81 |
GSM687704 | Patient 444 control | 400.615 | 60 |
GSM687707 | Patient 448 control | 182.631 | 43 |
GSM687712 | Patient 449 control | 529.245 | 64 |
GSM687719 | Patient 450 control | 881.934 | 72 |
GSM687724 | Patient 451 control | 214.186 | 48 |
GSM687728 | Patient 452 control | 2649.49 | 87 |
GSM687646 | Patient 401 treated 24h | 112.581 | 37 |
GSM687649 | Patient 402 treated 24h | 814.549 | 71 |
GSM687665 | Patient 411 treated 24h | 1101.47 | 75 |
GSM687651 | Patient 402 treated 4 weeks | 694.335 | 68 |
GSM687667 | Patient 411 treated 4 weeks | 435.874 | 61 |
GSM687670 | Patient 422 treated 24h | 221.35 | 49 |
GSM687671 | Patient 422 treated 4 weeks | 212.307 | 50 |
GSM687654 | Patient 403 treated 24h | 360.105 | 60 |
GSM687675 | Patient 424 treated 24h | 638.44 | 67 |
GSM687685 | Patient 427 treated 24h | 1079.24 | 75 |
GSM687656 | Patient 403 treated 4 weeks | 138.194 | 44 |
GSM687677 | Patient 424 treated 4 weeks | 183.561 | 47 |
GSM687687 | Patient 427 treated 4 weeks | 148.703 | 44 |
GSM687692 | Patient 428 treated 4h | 161.95 | 44 |
GSM687716 | Patient 449 treated 4h | 249.99 | 53 |
GSM687722 | Patient 450 treated 4h | 438.791 | 60 |
GSM687680 | Patient 425 treated 24h | 707.184 | 69 |
GSM687690 | Patient 428 treated 24h | 349.733 | 59 |
GSM687700 | Patient 443 treated 24h | 2866.79 | 89 |
GSM687705 | Patient 444 treated 24h | 2302.98 | 86 |
GSM687714 | Patient 449 treated 24h | 608.909 | 67 |
GSM687721 | Patient 450 treated 24h | 1486.44 | 80 |
GSM687682 | Patient 425 treated 4 weeks | 657.71 | 68 |
GSM687694 | Patient 428 treated 4 weeks | 289.35 | 56 |
GSM687702 | Patient 443 treated 4 weeks | 501.627 | 62 |
GSM687718 | Patient 449 treated 4 weeks | 156.077 | 43 |
GSM687723 | Patient 450 treated 4 weeks | 386.009 | 59 |
GSM687661 | Patient 404 treated 4h | 518.002 | 64 |
GSM687710 | Patient 448 treated 4h | 239.128 | 52 |
GSM687726 | Patient 451 treated 4h | 174.407 | 42 |
GSM687730 | Patient 452 treated 4h | 99.3229 | 22 |
GSM687660 | Patient 404 treated 24h | 31607.6 | 99 |
GSM687697 | Patient 441 treated 24h | 6658.87 | 95 |
GSM687709 | Patient 448 treated 24h | 347.636 | 58 |
GSM687725 | Patient 451 treated 24h | 451.215 | 61 |
GSM687729 | Patient 452 treated 24h | 9736.46 | 97 |
GSM687727 | Patient 451 treated 4 weeks | 230.009 | 48 |
GSM687731 | Patient 452 treated 4 weeks | 1604.84 | 81 |